HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao-Ning Zhong Selected Research

Erythromycin (Erycette)

7/2021Erythromycin inhibits cigarette smoke-induced inflammation through regulating the PPARγ/NF-κB signaling pathway in macrophages.
1/2020Erythromycin reverses cigarette smoke extract-induced corticosteroid insensitivity by inhibition of the JNK/c-Jun pathway.
12/2019Erythromycin suppresses neutrophil extracellular traps in smoking-related chronic pulmonary inflammation.
7/2015Combination of erythromycin and dexamethasone improves corticosteroid sensitivity induced by CSE through inhibiting PI3K-δ/Akt pathway and increasing GR expression.
1/2012Erythromycin enhances CD4+Foxp3+ regulatory T-cell responses in a rat model of smoke-induced lung inflammation.
1/2010Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiao-Ning Zhong Research Topics

Disease

10Chronic Obstructive Pulmonary Disease (COPD)
05/2020 - 01/2010
8Emphysema
12/2019 - 01/2012
7Inflammation (Inflammations)
07/2021 - 01/2010
4Pneumonia (Pneumonitis)
12/2019 - 01/2012
3Fibrosis (Cirrhosis)
09/2016 - 04/2015
3Asthma (Bronchial Asthma)
05/2005 - 11/2004
2Lung Neoplasms (Lung Cancer)
12/2021 - 01/2011
1Carcinogenesis
12/2021
1Persistent Infection
09/2020
1Eosinophilia
09/2020
1Infections
09/2020
1Opportunistic Infections (Opportunistic Infection)
09/2020
1Skin Diseases (Skin Disease)
09/2020
1Respiratory Tract Diseases (Respiratory Tract Disease)
05/2020
1Lung Abscess
10/2019
1Pulmonary Plasma Cell Granuloma
10/2019
1Interstitial Lung Diseases (Interstitial Lung Disease)
10/2019
1Cryptogenic Organizing Pneumonia
10/2019
1Idiopathic Pulmonary Fibrosis
10/2019
1Systemic Scleroderma (Systemic Sclerosis)
09/2016
1Pulmonary Fibrosis (Fibrosing Alveolitis)
09/2016
1Diffuse panbronchiolitis
07/2015
1Cystic Fibrosis (Mucoviscidosis)
07/2015
1Neoplasms (Cancer)
01/2014
1Neoplasm Metastasis (Metastasis)
01/2014
1Lung Diseases (Lung Disease)
01/2011

Drug/Important Bio-Agent (IBA)

11SmokeIBA
07/2021 - 01/2012
6Erythromycin (Erycette)FDA LinkGeneric
07/2021 - 01/2010
5Adrenal Cortex Hormones (Corticosteroids)IBA
05/2020 - 07/2015
4Proteins (Proteins, Gene)FDA Link
05/2020 - 01/2011
4interleukin-21 (interleukin 21)IBA
04/2016 - 01/2012
3CytokinesIBA
09/2016 - 11/2004
3Bleomycin (Blenoxane)FDA LinkGeneric
09/2016 - 04/2015
2GlucocorticoidsIBA
05/2020 - 05/2005
2Interleukin-17 (Interleukin 17)IBA
09/2016 - 04/2015
2MacrolidesIBA
06/2015 - 01/2012
1DNA (Deoxyribonucleic Acid)IBA
12/2021
1AutoantibodiesIBA
09/2020
1Immunoglobulin E (IgE)IBA
09/2020
1Interferon-gamma (Interferon, gamma)IBA
09/2020
1Histone Deacetylase 2IBA
05/2020
1Dexamethasone (Maxidex)FDA LinkGeneric
05/2020
1Theophylline (Theon)FDA LinkGeneric
05/2020
1SteroidsIBA
10/2019
1Messenger RNA (mRNA)IBA
01/2019
1Histones (Histone)IBA
01/2019
1Sirtuin 1IBA
01/2019
1LigandsIBA
01/2019
1Hydroxyproline (4 Hydroxyproline)IBA
09/2016
1Phosphates (Orthophosphate)IBA
09/2016
1indium-bleomycinIBA
04/2016
1CD40 Ligand (CD40L)IBA
01/2016
1InterleukinsIBA
04/2012
1Tumor Biomarkers (Tumor Markers)IBA
01/2011
1AllergensIBA
05/2005
1CTLA-4 AntigenIBA
03/2005

Therapy/Procedure

1Therapeutics
10/2019
1Lasers (Laser)
01/2011